Johnson & Johnson to Buy Firefly Bio for $1 Billion
RSS SUMMARY · AGGREGATED FROM TWSJ
Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline.
Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline.
Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
Business
Opinion | When ‘60 Minutes’ Is an Hour Too Long
TWSJ·13m ago·3 min read
Tech
The 24-Year-Old AI Wiz Who Counts Jane Street as an Investor
TWSJ·1h ago·3 min read
Sports
America Is Already Losing the World Cup for Hotel Bookings
TWSJ·6h ago·3 min read
Sports
Trump’s NBA Finals Attendance Brings Added Security to Madison Square Garden
TWSJ·57m ago·3 min read
Related
On this beat
Tech
On World Ocean Day, The Islands Of Tahiti Show That Conservation And Tourism Go Hand In Hand
FORBES·3h ago·3 min read
Tech
Eero’s Pro 6E routers are down to their cheapest price yet in 2026
THE VERGE·48m ago·3 min read
Tech
I tried TikTok’s most viral hair hacks —what’s actually worth it
TECHRADAR·45m ago·3 min read
Tech
Dell’s new Nvidia RTX Spark mini PC has distinct Mac Studio vibes — and I think it could tempt buyers away from Apple given its current stock woes
TECHRADAR·1h ago·3 min read